Trametinib for orbital plexiform neurofibromas in young children with neurofibromatosis type 1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trametinib for orbital plexiform neurofibromas in young children with neurofibromatosis type 1

Published:2021-03-22 Issue: Volume: Page:
ISSN:0256-7040
Container-title:Child's Nervous System
language:en
Short-container-title:Childs Nerv Syst

Author:

Toledano Helen,Dotan Gad,Friedland Rivka,Cohen Rony,Yassur Iftach,Toledano-Alhadef Hagit,Constantini Shlomi,Rootman Mika Shapira

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,General Medicine,Pediatrics, Perinatology, and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s00381-021-05127-6.pdf

Reference21 articles.

1. Nix JS, Blakeley J, Rodriguez FJ (2019) An update on the central nervous system manifestations of neurofibromatosis type 1. Acta Neuropathol 139(4):625–641. https://doi.org/10.1007/s00401-019-02002-2

2. Gandhi NG (2013) Treatment of neuro-ophthalmic and orbitofacial manifestations of neurofibromatosis type 1. Curr Opin Ophthalmol 24:506–511. https://doi.org/10.1097/ICU.0b013e32836348a4

3. Kinori M, Hodgson N, Zeid JL (2018) Ophthalmic manifestations in neurofibromatosis type 1. Surv Ophthalmol 63:518–533. https://doi.org/10.1016/j.survophthal.2017.10.007

4. Khajavi M, Khoshsirat S, Ahangarnazari L, Majdinasab N (2018) A brief report of plexiform neurofibroma. Curr Probl Cancer 42:256–260. https://doi.org/10.1016/J.CURRPROBLCANCER.2018.01.007

5. Korf BR (1999) Plexiform neurofibromas. Am J Med Genet 89:31–37. https://doi.org/10.1002/(sici)1096-8628(19990326)89:1<31::aid-ajmg7>3.0.co;2-w

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous toxicities of mitogen-activated protein kinase inhibitors in children and young adults with neurofibromatosis-1;Journal of Neuro-Oncology;2024-03-05

2. Development and pilot validation of a novel disfigurement severity scale for plexiform neurofibromas in children with neurofibromatosis type 1;Clinical Trials;2023-10-25

3. Safety and Efficacy of Mek Inhibitors in the Treatment of Plexiform Neurofibromas: A Retrospective Study;Cancer Control;2023-01-04

4. Efficacy and safety profile of selumetinib in symptomatic inoperable plexiform neurofibromas;Journal of Neurosurgical Sciences;2022-11

5. Efficacy and Safety of Trametinib in Neurofibromatosis Type 1-Associated Plexiform Neurofibroma and Low-Grade Glioma: A Systematic Review and Meta-Analysis;Pharmaceuticals;2022-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3